Production of interleukin 1 from human monocytes stimulated by synthetic lipid A subunit analogues. 1990

I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
Institute of Immunological Science, Hokkaido University, Sapporo, Japan.

We have investigated that synthetic lipid A subunit analogues (GLA compounds) as well as E. coli type lipopolysaccharide (LPS) and synthetic lipid A (compound 506) are able to stimulate human monocytes to release IL-1 in vitro. Of monosaccharide-type GLA compounds, GLA-60 was found to be more active for the induction of IL-1 production than GLA-59 and GLA-27, and similar to that of LPS or compound 506. GLA-60 could induce not only the secretion of IL-1 into culture supernatant but also the expression of membrane-associated form of IL-1 in human monocytes. Furthermore, no detectable IL-2 activity was observed in the culture supernatant. These results show that synthetic lipid A analogues of low toxicity, in particular GLA-60, are active in inducing IL-1 production in human monocytes.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008050 Lipid A Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli

Related Publications

I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
May 1988, Scandinavian journal of immunology,
I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
February 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
May 1988, The Journal of antimicrobial chemotherapy,
I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
December 1985, Journal of immunology (Baltimore, Md. : 1950),
I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
August 1989, Scandinavian journal of immunology,
I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
June 1997, Infection and immunity,
I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
May 1986, The Journal of experimental medicine,
I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
January 1990, Progress in clinical and biological research,
I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
September 1989, Infection and immunity,
I Saiki, and H Maeda, and J Murata, and T Takahashi, and S Sekiguchi, and M Kiso, and A Hasegawa, and I Azuma
September 1991, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!